Women are and will be the predominant users of GLP-1 users, but research gaps remain critical
The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women. The authors, that include Professor Paul Franks, Lund University, Helsingborg Hospital,…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
First successful primate transplant of human pituitary tissue boosts cortisol levels
United Kingdom
-
Functional decline precedes cardiovascular disease events by many years
United Kingdom
-
Almost 1 in 3 adults develop cardiorenal disease or die within 5 years of type 2 diabetes diagnosis
United Kingdom
-
Reading, socializing and doing puzzles can help preserve cognitive health, large study shows
United Kingdom
-
'Mini-brains' model myelin damage and regeneration, offering new tool for MS drug testing
United Kingdom
-
Newly discovered cell type helps shape blood vessel growth in the heart
United Kingdom
-
Herpesvirus eye infections show distinct patterns linked to immune status
United Kingdom
-
Gut bacterial compound worsens brain injury after stroke, study suggests
United Kingdom